Therapeutic antibodies dominate the pharmaceutical market and improve the lives of millions of people annually. One important step when developing new medicines is to kinetically characterise the drug candidates. For antibodies this is difficult since many antibody reactions are extremely slow. By combining a mathematical formula that was recently published with the well-established technology from Gyros Protein Technologies, a new method for full kinetic characterization was developed and tested in this master thesis. The method provided precise data for five antibodies while also proving to be highly reproducible. By using small sample volumes, unlabelled reagents and having the reaction proceed in solution, this method offers advantages compared to many conventional approaches.